Jennison Associates’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.96M Buy
+416,089
New +$7.16M ﹤0.01% 421

Other funds holding TRVI

Jennison Associates's TRVI Position: Q3 2026 in Review

Jennison Associates opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 416,089 shares worth $5.96M. The stake represents ﹤0.01% of the portfolio and ranks #421 among its holdings.

223 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Jennison Associates held 416,089 shares of Trevi Therapeutics worth $5.96M as of Q3 2026.
  • Trevi Therapeutics was a new Jennison Associates position in Q3 2026.
  • Trevi Therapeutics made up ﹤0.01% of Jennison Associates's portfolio in Q3 2026, its #421 holding.
  • 223 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Jennison Associates's 13F filing for Q3 2026, filed 16 Nov 2026.